XHKG0809
Market cap115mUSD
Dec 23, Last price
0.10HKD
1D
1.00%
1Q
38.36%
Jan 2017
-53.67%
Name
Global Bio-chem Technology Group Co Ltd
Chart & Performance
Profile
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, rest of Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, including corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meal, feed pellets, and corn germ cake. It also provides downstream corn based biochemical products, such as amino acids comprising lysine, protein lysine, threonine, and glutamic acid; corn sweeteners, which include high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose; modified starches; and chemicals comprising ethylene, propylene, and butylene glycols, as well as resins. In addition, the company offers anti-freeze products, hydrogen, and ammonia. Its products are used in various applications, such as feed production, food and beverage, cosmetics, textiles, pharmaceuticals, chemical industries, etc. The company was founded in 1994 and is headquartered in Hung Hom, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 1,373,938 269.06% | 372,278 -50.13% | 746,551 -12.05% | |||||||
Cost of revenue | 1,706,861 | 715,767 | 1,147,759 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (332,923) | (343,489) | (401,208) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (42,082) | (54,219) | 25,920 | |||||||
Tax Rate | ||||||||||
NOPAT | (290,841) | (289,270) | (427,128) | |||||||
Net income | 4,224,593 -378.01% | (1,519,565) 249.01% | (435,389) -82.11% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 4,637,706 | 8,152,903 | 7,503,171 | |||||||
Long-term debt | 812,177 | 2,592 | 945,240 | |||||||
Deferred revenue | 31,327 | 100,806 | 115,232 | |||||||
Other long-term liabilities | ||||||||||
Net debt | 5,344,178 | 8,113,521 | 8,426,393 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (50,461) | (88,010) | (475,207) | |||||||
CAPEX | (43,776) | (6,176) | (25,812) | |||||||
Cash from investing activities | (14,370) | (413) | 392,590 | |||||||
Cash from financing activities | 165,812 | 109,750 | (48,658) | |||||||
FCF | (1,333,524) | 1,163,789 | 760,414 | |||||||
Balance | ||||||||||
Cash | 88,357 | 41,766 | 21,810 | |||||||
Long term investments | 17,348 | 208 | 208 | |||||||
Excess cash | 37,008 | 23,360 | ||||||||
Stockholders' equity | (8,941,410) | 642,678 | 707,620 | |||||||
Invested Capital | 10,385,369 | 112,223 | 1,538,950 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 14,080,166 | 8,907,406 | 8,907,406 | |||||||
Price | 0.11 -32.05% | 0.16 25.81% | 0.12 -66.49% | |||||||
Market cap | 1,492,498 7.41% | 1,389,555 25.81% | 1,104,518 -64.91% | |||||||
EV | 6,836,676 | 20,534,045 | 19,605,533 | |||||||
EBITDA | (27,752) | (12,980) | 1,305 | |||||||
EV/EBITDA | 15,023.40 | |||||||||
Interest | 750,351 | 726,218 | 790,585 | |||||||
Interest/NOPBT |